Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Genome Medicine|April 20, 2022
Preventing disease progression in multiple sclerosis-insights from large real-world cohortsSinah Engel, Frauke Zipp
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MSFelix Luessi, Sinah Engel, Annette Spreer, et al.
Journal of Central Nervous System Disease|January 7, 2022
A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk FactorsSinah Engel, Lara S Molina Galindo, Stefan Bittner, et al.
Therapeutic Advances in Neurological Disorders|January 11, 2020
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disordersSinah Engel, Felix Luessi, Aneka Mueller, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2020
Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MSSinah Engel, Falk Steffen, Timo Uphaus, et al.
Fluids and Barriers of the CNS|January 11, 2023
Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertensionSinah Engel, Johannes Halcour, Erik Ellwardt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2019
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MSSinah Engel, Michaela Friedrich, Muthuraman Muthuraman, et al.
Therapeutic Advances in Neurological Disorders|May 7, 2021
Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosisSinah Engel, Maria Protopapa, Falk Steffen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal CohortFalk Steffen, Timo Uphaus, Nina Ripfel, et al.
Journal of Clinical Apheresis|December 14, 2021
Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseasesSimone C Boedecker, Felix Luessi, Sinah Engel, et al.
Pageof 3